Adefovir dipivoxil, a nucleotide analogue, demonstrated clinically significant antiviral activity in patients with chronic hepatitis B in phase 1 and 2 clinical trials.We randomly assigned 185 pati ...

Laura Gater. May 20, 2005 (Chicago) — Treatment with 10 mg of adefovir dipivoxil for 192 weeks resulted in significant and sustained reductions in hepatitis B virus (HBV) DNA levels, with the ...

Feb. 26, 2003 -- Adefovir dipivoxil is effective for the treatment of hepatitis B, according to the results of two studies in the Feb. 27 issue of the New England Journal of Medicine. Neither ...

Drug Name : Adefovir Dipivoxil Adefovir Dipivoxil is an antiviral agent prescribed to treat hepatitis B, a chronic viral infection of the liver in patients 12 years and above.

Peginterferon alfa-2a . 4.1.1 The Assessment Group found three randomised controlled trials investigating peginterferon alfa-2a in chronic hepatitis B. Two trials were in people with HBeAg-positive ...

Adefovir Dipivoxil is an antiviral agent prescribed to treat hepatitis B, a chronic viral infection of the liver in patients 12 years and above. Adefovir Dipivoxil Interaction with 29 drugs.

Besifovir dipivoxil maleate (BSV) is another drug that has been shown to have an antiviral efficacy comparable to TDF in a stage 3 clinical trial, with improved kidney and bone safety in treated ...

Adefovir dipivoxil may be a safe option for treating children with chronic hepatitis B, according to recent results in which Maureen M. Jonas, MD, and colleagues from Children’s Hospital in ...

In a Chinese cohort of patients with hepatitis B virus infection, therapy with tenofovir disoproxil fumarate was safe and effective in treating the infection compared with adefovir dipivoxil ...

Adefovir dipivoxil (Hepsera, Gilead Sciences) is an oral prodrug of adefovir, an analogue of adenosine monophosphate. The active intracellular metabolite, adefovir diphosphate, inhibits HBV DNA ...

adefovir dipivoxil, compared with lamivudine then adefovir dipivoxil) – ICER $91,000 (£52,000) per QALY. 4.2.13 In the analysis for HBeAg-negative disease, lamivudine then adefovir dipivoxil (as ...